Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

被引:28
|
作者
Diz-Chaves, Yolanda [1 ]
Herrera-Perez, Salvador [2 ]
Gonzalez-Matias, Lucas C. [1 ]
Lamas, Jose Antonio [2 ]
Mallo, Federico [1 ]
机构
[1] Univ Vigo, Lab Endocrinol, CINBIO, Grp FB3A, Vigo 36310, Spain
[2] Univ Vigo, Lab Neurociencia, CINBIO, Grp FB3A, Vigo 36310, Spain
关键词
glucagon-like peptide-1; hypothalamic-pituitary-adrenal (HPA) axis; sympathetic nervous system (SNS); ion channels; food intake; BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL-AXIS; NUCLEUS-TRACTUS-SOLITARIUS; RECEPTOR-EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; PANCREATIC BETA-CELLS; REDUCES FOOD-INTAKE; HEART-RATE; ENERGY-BALANCE;
D O I
10.3390/nu12113304
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glucagon like-peptide 1 (GLP-1) within the brain is produced by a population of preproglucagon neurons located in the caudal nucleus of the solitary tract. These neurons project to the hypothalamus and another forebrain, hindbrain, and mesolimbic brain areas control the autonomic function, feeding, and the motivation to feed or regulate the stress response and the hypothalamic-pituitary-adrenal axis. GLP-1 receptor (GLP-1R) controls both food intake and feeding behavior (hunger-driven feeding, the hedonic value of food, and food motivation). The activation of GLP-1 receptors involves second messenger pathways and ionic events in the autonomic nervous system, which are very relevant to explain the essential central actions of GLP-1 as neuromodulator coordinating food intake in response to a physiological and stress-related stimulus to maintain homeostasis. Alterations in GLP-1 signaling associated with obesity or chronic stress induce the dysregulation of eating behavior. This review summarized the experimental shreds of evidence from studies using GLP-1R agonists to describe the neural and endocrine integration of stress responses and feeding behavior.
引用
收藏
页码:1 / 32
页数:32
相关论文
共 50 条
  • [1] Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
    Punjabi, Mukesh
    Arnold, Myrtha
    Geary, Nori
    Langhans, Wolfgang
    Pacheco-Lopez, Gustavo
    PHYSIOLOGY & BEHAVIOR, 2011, 105 (01) : 71 - 76
  • [2] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [3] THE COLON AS A SOURCE FOR GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    HOLST, JJ
    OLESEN, KM
    GUDMANDHOYER, E
    DEACON, CF
    HANSEN, CP
    JOHNSEN, AH
    MIHOLIC, J
    NAUCK, M
    QUALMANN, C
    DIABETOLOGIA, 1995, 38 : A170 - A170
  • [4] Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands
    Tanday, Neil
    Flatt, Peter R.
    Irwin, Nigel
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 526 - 541
  • [5] Facile synthesis of glucagon-like peptide-1 (GLP-1) mimetics
    Han, S.-Y.
    Murage, E.
    Beinbom, M.
    Ahn, J.-M.
    BIOPOLYMERS, 2007, 88 (04) : 560 - 560
  • [6] Facile Synthesis of Glucagon-Like Peptide-1 (GLP-1) Mimetics
    Han, Sun-Young
    Beinborn, Martin
    Ahn, Jung-Mo
    PEPTIDES FOR YOUTH, 2009, 611 : 119 - 120
  • [7] Glucagon-like peptide-1 drugs Are GLP-1 analogues affordable?
    Macaulay, Donald
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [8] GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - A PIECE OF THE INCRETIN PUZZLE
    WEIR, GC
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 1 - 1
  • [9] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
    Hoelscher, Christian
    CNS DRUGS, 2012, 26 (10) : 871 - 882
  • [10] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
    Christian Hölscher
    CNS Drugs, 2012, 26 : 871 - 882